TNF and hepatitis B virus infection: It is unlikely that anti-TNF therapy contributed to the progression of this patient’s liver disease, since there are reports that anti-TNF therapy has been beneficial in patients with hepatitis B and C-related liver disease (18) and animal models of steatohepatitis (19).